Literature DB >> 32870174

Paravalvular leak after transcatheter aortic valve implantation.

Orhan Gökalp1, Hasan Iner1, Yüksel Beşir1, Nihan Karakaş Yeşilkaya1, Levent Yılık1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32870174      PMCID: PMC7585977          DOI: 10.14744/AnatolJCardiol.2020.65259

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


× No keyword cloud information.
To the Editor, We read the study of Duran Karaduman et al. (1) with interest. The number of highly satisfactory patients and successful results for a single-center study is truly admirable. When evaluating transcatheter aortic valve implantation (TAVI) applications as the treatment of severe aortic stenosis, there are undoubtedly 2 basic issues to be evaluated. The first is clinical parameters such as postoperative survival and neurological complications. The other is the postoperative high valve gradients and paravalvular leak (PVL) incidence rates that show the durability of the valve. Different rates of PVL can be detected in both surgical aortic valve replacements (SAVR) and TAVI procedures. It has been reported in many studies that there is mild or severe PVL at the rate of 0% to 20% in surgical aortic valve replacements (2-4). In TAVI, this rate is somewhat higher owing to the nature of the procedure. In various studies, this rate has been reported to be as high as 60% for post-TAVI mild PVL (5, 6). However, the point we want to mention here is not to compare or interpret the 2 techniques in terms of this parameter. Another point regarding PVL in the study of Duran Karaduman et al. (1) attracted our attention. It has been reported that mild PVL incidence has not decreased over time (over a 1-year period), or that it has even increased, although not statistically significant. However, in patients with SAVR, both in daily practice and the literature, mild PVLs appear to improve or even disappear over time (3). In the study of Matteucci et al. (3), which includes a large number of patients in whom post-SAVR-PVLs were examined, it was stated that PVL disappeared during the follow-up period in half of the patients with early postoperative PVL (3). The causes of severe PVLs seen in both the early and late periods are mostly infective endocarditis or failure of the procedure, as the authors stated in their study. Even the mild PVLs progress to severe PVLs in longer term follow-ups. This situation makes sense considering the ongoing calcifications. However, we wonder how the authors interpreted the continued existence of mild PVL over a 1-year period.
  5 in total

1.  Intermediate Clinical and Hemodynamic Outcomes After Transcatheter Aortic Valve Implantation.

Authors:  Augusto D'Onofrio; Michela Facchin; Laura Besola; Erica Manzan; Chiara Tessari; Eleonora Bizzotto; Roberto Bianco; Giuseppe Tarantini; Massimo Napodano; Chiara Fraccaro; Paolo Buja; Elisa Covolo; Ermela Yzeiraj; Demetrio Pittarello; Giambattista Isabella; Sabino Iliceto; Gino Gerosa
Journal:  Ann Thorac Surg       Date:  2015-10-23       Impact factor: 4.330

Review 2.  Early Aortic Paravalvular Leak After Conventional Cardiac Valve Surgery: A Single-Center Experience.

Authors:  Matteo Matteucci; Sandro Ferrarese; Cristiano Cantore; Giulio Massimi; Sara Facetti; Vittorio Mantovani; Giangiuseppe Cappabianca; Dario Fina; Roberto Lorusso; Cesare Beghi
Journal:  Ann Thorac Surg       Date:  2019-07-20       Impact factor: 4.330

Review 3.  Impact of paravalvular aortic regurgitation after transcatheter aortic valve implantation on survival.

Authors:  Hisato Takagi; Takuya Umemoto
Journal:  Int J Cardiol       Date:  2016-07-04       Impact factor: 4.164

4.  Outcome of mild periprosthetic regurgitation detected by intraoperative transesophageal echocardiography.

Authors:  D J O'Rourke; R T Palac; D J Malenka; C A Marrin; B E Arbuckle; J F Plehn
Journal:  J Am Coll Cardiol       Date:  2001-07       Impact factor: 24.094

5.  Evaluation of procedural and clinical outcomes of transcatheter aortic valve implantation: A single-center experience.

Authors:  Bilge Duran Karaduman; Hüseyin Ayhan; Telat Keleş; Engin Bozkurt
Journal:  Anatol J Cardiol       Date:  2020-04       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.